Related content

Quality of life and depression among metastatic breast cancer patients

By Slovacek Ladislav   Slovackova Birgita   Slanska Iva   Petera Jiri   Priester Peter  

Medical Oncology, Vol. 27, Iss. 3, 2010-09 ,pp. : 958-959

Humana Press, Inc

Access to resources Recommend Favorite

Bisphosphonate treatment in primary breast cancer: Results from a randomised comparison of oral pamidronate versus no pamidronate in patients with primary breast cancer

By Kristensen Bent   Ejlertsen Bent   Mouridsen Henning   Jensen Maj-Britt   Andersen Jørn   Bjerregaard Brita   Cold Søren   Edlund Per   Ewertz Marianne   Kamby Claus   Lindman Henrik   Nordenskjold Bo   Bergh Jonas  

Acta Oncologica, Vol. 47, Iss. 4, 2008-01 ,pp. : 740-746

Informa Healthcare

Access to resources Recommend Favorite

Impact of prophylactic pyridoxine on occurrence of hand–foot syndrome in patients receiving capecitabine for advanced or metastatic breast cancer

By Yoshimoto Nobuyasu  

Breast Cancer, Vol. 17, Iss. 4, 2010-10 ,pp. : 298-302

Springer Publishing Company

Access to resources Recommend Favorite

A retrospective study of the impact of age on patterns of care for elderly patients with metastatic breast cancer

By Hashimoto Kenji  

Medical Oncology, Vol. 28, Iss. 2, 2011-06 ,pp. : 434-440

Humana Press, Inc

Access to resources Recommend Favorite

Examination of the use of Exemestane in patients with metastatic breast cancer

By Takashima Seiki  

Breast Cancer, Vol. 18, Iss. 3, 2011-07 ,pp. : 189-194

Springer Publishing Company

Access to resources Recommend Favorite